Literature DB >> 35975262

EMPTY SELLA IN A PATIENT WITH CLINICAL AND BIOCHEMICAL DIAGNOSIS OF ACROMEGALY.

N Bestepe1, C Aydin2, A A Tam2, K Ercan3, R Ersoy2, B Cakir2.   

Abstract

Background: Acromegaly is an acquired disorder related to excessive production of growth hormone (GH) and insulin-like growth factor-1 (IGF-1). Empty sella (ES) is an anatomical condition of sella turcica that is partially or completely filled with cerebrospinal fluid mainly due to intrasellar herniation of subarachnoid space. Here, we describe a patient who presented with clinical and biochemical features of acromegaly and who had an ES on pituitary magnetic resonance imaging (MRI). Case report: A 73-year-old male patient was consulted in our clinic because of the acromegalic phenotype while planning for colorectal adenocarcinoma surgery. The patient noticed gradual enlarging of his hands, feet and nose for 30 years, but never consulted to any clinician for this reason. Serum GH was 20.6 ng/mL (normal <3 ng/mL) and IGF-1 was 531 ng/mL (normal, 69-200 ng/ml). An oral glucose tolerance test showed no suppression of GH values. T1-weighted MRI revealed an ES. 18F-FDG PET/CT and Ga-DOTATADE PET/CT did not show any finding consistent with ectopic GH secretion. Growth hormone releasing hormone (GHRH) was within the normal range (<100mg/dL). He was treated with long-acting octreotide 20 mg per 28 days. At the 6th month of treatment, serum GH and IGF-1 levels were decreased to 5.45 ng/mL and 274 ng/mL, respectively.
Conclusion: The mechanism underlying the association of acromegaly and ES remains unclear. Apoplexy on existing pituitary adenoma and then formation of necrosis can proceed to ES. Since our patient did not have a history of pituitary apoplexy and we could not find any reason for secondary ES, we considered primary ES. ©2021 Acta Endocrinologica (Buc).

Entities:  

Keywords:  acromegaly; empty sella syndrome; pituitary tumor

Year:  2022        PMID: 35975262      PMCID: PMC9365410          DOI: 10.4183/aeb.2022.97

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   1.104


  36 in total

Review 1.  Medical progress: Acromegaly.

Authors:  Shlomo Melmed
Journal:  N Engl J Med       Date:  2006-12-14       Impact factor: 91.245

2.  Pathology of invasive pituitary tumors with special reference to functional classification.

Authors:  B W Scheithauer; K T Kovacs; E R Laws; R V Randall
Journal:  J Neurosurg       Date:  1986-12       Impact factor: 5.115

3.  Coexisting primary empty sella syndrome and acromegally.

Authors:  M E Molitch; G B Hieshima; S Marcovitz; I M Jackson; S Wolpert
Journal:  Clin Endocrinol (Oxf)       Date:  1977-09       Impact factor: 3.478

4.  Anatomical variations in the pituitary gland and adjacent structures in 225 human autopsy cases.

Authors:  R M Bergland; B S Ray; R M Torack
Journal:  J Neurosurg       Date:  1968-02       Impact factor: 5.115

5.  Mortality in acromegaly.

Authors:  A D Wright; D M Hill; C Lowy; T R Fraser
Journal:  Q J Med       Date:  1970-01

Review 6.  Acromegaly: clinical features at diagnosis.

Authors:  Lucio Vilar; Clarice Freitas Vilar; Ruy Lyra; Raissa Lyra; Luciana A Naves
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

7.  Acromegaly without imaging evidence of pituitary adenoma.

Authors:  Russell R Lonser; Bogdan A Kindzelski; Gautam U Mehta; John A Jane; Edward H Oldfield
Journal:  J Clin Endocrinol Metab       Date:  2010-07-07       Impact factor: 5.958

8.  Acromegaly: an endocrine society clinical practice guideline.

Authors:  Laurence Katznelson; Edward R Laws; Shlomo Melmed; Mark E Molitch; Mohammad Hassan Murad; Andrea Utz; John A H Wass
Journal:  J Clin Endocrinol Metab       Date:  2014-10-30       Impact factor: 5.958

Review 9.  Epidemiology of acromegaly: review of population studies.

Authors:  Aikaterini Lavrentaki; Alessandro Paluzzi; John A H Wass; Niki Karavitaki
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

10.  Empty sella syndrome - beyond being an incidental finding.

Authors:  Vikrant Ghatnatti; Dipti Sarma; Uma Saikia
Journal:  Indian J Endocrinol Metab       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.